Background Transmission of infection through international travel is a growing health issue, and the frequency of imported infection is increasing in China. We aimed to quantify the total number of infections imported into mainland China by arriving travellers.
Introduction
The number of international travellers has more than doubled worldwide during the past two decades, from 527 million in 1995 to 1·186 billion in 2015. 1 This rapid increase in cross-border travelling has become the main driver of the global spread of infections, as exemplified by international transmission of severe acute respira tory syndrome, dengue, 2009 influenza A (H1N1), and Zika virus. [2] [3] [4] [5] Timely identification of infections among arriving travellers can help to alert the medical and public health communities of outbreak threats before they affect the general population of that country. Surveillance of travel-related infections is important for global public health as international travel continues to increase worldwide. 6, 7 China has become the world's fourth most popular destination in terms of arrivals, with 57 million tourists in 2015, 1 and has inevitably been affected by travelrelated infections. Malaria and dengue have been introduced by arriving travellers from countries where those diseases are endemic. [8] [9] [10] An outbreak of Chikungunya virus caused by infected travellers has been recorded in main land China, 11 and Zika virus, yellow fever, and Rift Valley fever have all been imported within the past 8 years. [12] [13] [14] [15] In response to the increasing risk of imported infections, the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China (AQSIQ) obliged all air and surface ports to do active surveillance of infections among arriving travellers. Systematic surveillance began in 2014 to reduce risk of autochthonous transmission and help to inform evidence-based advice for travellers. We integrated the data from all entry-exit ports in mainland China to characterise travel-related infections, define the demographic features of imported cases, identify risk groups and exposure countries or regions, and assess the effectiveness of surveillance for further improvement.
Methods

Study design
We did an active surveillance study of all travel-related infections from Jan 1, 2014, to Dec 31, 2016 , at all 272 international entry-exit ports to mainland China, comprising 69 airports, 128 water (sea and river) ports, and 75 land (highway and railway) entry-exit stations (appendix p 2). We also gathered data for the total number of people arriving in each of the 22 provinces, five autonomous regions, and four municipalities of mainland China. All patient data were anonymised. Because this study constituted public health surveillance rather than research in human beings, ethical approval from institutional review boards was not required. Participants or their guardians provided written informed consent for collection of biological samples (appendix p 4). People who were suspected of having an infection but who did not consent to collection of samples were made known to local centres for disease control and prevention for potential further follow-up.
Data collection and diagnosis
Active surveillance was done among all arriving travellers at a quarantine station before they passed through customs at each entry-exit port. Suspected cases were detected through four approaches: fever screening, medical inspection, self-declaration, and reporting by on-board staff (appendix p 3). All people with suspected infections were quarantined according to WHO's International Health Regulations and the Rules for the Implementation of Frontier Health and Quarantine Law of the People's Republic of China. Participants completed a standardised questionnaire with questions about demographics, their travel itinerary (including detailed information about all countries or regions visited), and clinical manifestations.
Infections were diagnosed by laboratory testing at the international travel health-care centre of each provincial entry-exit Inspection or the Quarantine Bureau, per the surveillance technical scheme developed by AQSIQ. 16 Quarantine officers at entry-exit ports suggested which tests should be done on the basis of clinical manifestations in each suspected patient. They collected nasopharyngeal swabs, sputum samples, faecal samples, vomitus, blood, or serum samples as appropriate for diagnoses. According to core capacity requirements for surveillance and response in WHO's International Health Regulations and the Frontier Health and Quarantine Law of China, AQSIQ listed 28 required and 40 recommended infectious diseases for causative testing. 17, 18 Diagnosed infections were classified as respiratory, gastrointestinal, vector-borne, blood-transmitted and sex-transmitted, or mucocutaneous according to standard clinical practice
Research in context
Evidence before this study We searched PubMed and ISI Web of Science with the terms "travel" and "infection" or "infectious disease", and "global spread" and "infection" or "infectious disease" for work published in any language between Jan 1, 2000, and Oct 31, 2017. We noted that previous studies mainly focused on surveillance of post-travel illness, which was usually based on clinician-based surveillance systems-eg, GeoSentinel, which tracks infectious diseases and other adverse health outcomes related to travel. Several identified studies were about the epidemiological features of imported malaria or about febrile illnesses or HIV infection at one port of China. We did not find any studies of active surveillance for various infections among arriving travellers at all entry-exit ports throughout mainland China.
Added value of this study
To the best of our knowledge, our report is the first to characterise the spectrum of travel-related infections, and reveals variety in frequency of each infection by traveller type, exposure country or region, and arrival provinces of mainland China in 2014-16, representing the pattern of travel-associated infections during travel.
Implications of all the available evidence
Our findings imply that health-care providers should make evidence-based health recommendations to travellers before travel, and do destination-specific medical assessments of arriving travellers when they are ill, based on our estimates of the incidence of infections. Active surveillance at entry ports can identify imported cases with emerging or re-emerging infections to prevent or at least postpone local transmission. In addition to entry surveillance upon arrival, follow-up surveillance (especially contact tracing of highly communicable infections) is needed to better understand the whole profile of travel-related infections. Overall, our findings should help to increase public health awareness about the potential risk of imported infections to mainland China. in China (appendix pp 5-6). Patients with infections were informed of their diagnosis, and recommended for treatment. We also informed local centres for disease control and prevention of each case, and close contacts were informed for prevention and quarantine, if necessary, according to WHO's International Health Regulations and the Frontier Health and Quarantine Law of China. We excluded people without specific diagnoses, people with ambiguous itineraries, and those whose final diagnosis had been identified before travelling. We used EPIDATA 3.0 to establish a structured database. Each case was geo-referenced to a world map with ArcGIS (ESRI, Redlands, CA, USA) according to the exposure location where patients might have been infected. The exposure location was defined as the country or region that the participant travelled from. For travellers who visited several destinations, exposure location was established according to their itinerary on the basis of incubation period or known patterns of endemicity. Arriving travellers were classified into two groups: travellers coming from countries other than China, and travellers coming from Hong Kong, Macau, and Taiwan. 
Statistical analysis
Descriptive statistics were calculated for all variables. Continuous variables were summarised as median and range. We estimated the annual incidence of each infection at national and provincial levels. Proportions were calculated according to various categories. We constructed graphs to show distribution patterns of proportion among different subgroups, and created thematic maps according to entry province and exposure countries.
Role of the funding source
The study funder had no role in study design; data collection, analysis, or interpretation; or writing of the report. W-CC and L-QF had full access to all data in the study, and had final responsibility for the decision to submit for publication.
Results
Of 805 figure 1A ). Incidence was highest in Qinghai, Jiangsu, and Zhejiang provinces ( figure 1B) . The five types of infections were diagnosed in substantially different proportions in different provinces. Nearly all people diagnosed in the Inner Mongolia autonomous region and slightly more than half those diagnosed in Yunnan province and Guangxi autonomous region had blood-transmitted and sex-transmitted infections ( figure 1A) . 142 (98%) of the 145 cases imported to Beijing were vector-borne infections. Inner Mongolia (6) Heilongjiang (4) Jilin (3) Liaoning (6) 45 types of pathogens were detected in participants: 18 respiratory pathogens (19 662 cases), ten gastrointestinal pathogens (189 cases), seven vector-borne pathogens (831 cases), seven blood-transmitted and sex-transmitted pathogens (1531 cases), and three mucocutaneous pathogens (584 cases; figure 2A) . The most frequent respiratory infection was influenza virus, followed by rhinovirus ( figure 2A) . Dengue was the most common vector-borne disease, hepatitis B virus infection was the most common blood-transmitted and sex-transmitted infection, and hand, foot, and mouth disease was the most common mucocutaneous infection ( figure 2A ).
16 237 (83%) respiratory infections, 76 (40%) gastrointestinal infections, 553 (67%) vector-borne infections, and 346 (85%) of the 406 cases of hand, foot, and mouth disease were detected by fever screening (figure 2B). 9812 (43%) of participants arrived from a different country (140 countries represented), whereas 12 985 (57%) came from Hong Kong, Macau, or Taiwan. The types and distribution of infection differed substantially between these two groups (figure 3). 12 126 (93%) of the 12 985 cases arriving from Hong Kong, Macau, or Taiwan were respiratory infections. Influenza was the most common infection in both groups, accounting for 6738 (69%) cases in the international group and 10 749 (83%) cases in the Hong Kong, Macau, and Taiwan group ( figure 3) . However, hepatitis B and C virus infections, syphilis, HIV, malaria, and dengue were substantially more common in the international group, whereas respiratory infections with rhinovirus, para influenza virus and metapneumovirus, and hand, foot, and mouth disease were more common in travellers from Hong Kong, Macau, and Taiwan ( figure 3) .
In the international travel group, infection was acquired in the Western Pacific region by 5153 (53%) people, in the South-East Asia region by 2666 (27%), in the European region by 838 (9%), in the American region by 432 (4%), in the African region by 448 (5%), and in the Eastern Mediterranean region by 275 (3%). Influenza accounted for more than two-thirds of cases among travellers who acquired infections in the Western Pacific, South-East Asia, European, American, and Eastern Mediterranean regions (appendix p 7). People with gastrointestinal infections mainly travelled from countries in the South-East Asia and Western Pacific regions ( figure 4B ). Vector-borne diseases, including dengue and malaria, were predominantly diagnosed among travellers from countries in western and central Africa and the South-East Asia region ( figure 4C ). Cases with mucocutaneous infections mostly come from countries in the Western Pacific region and eastern Europe ( figure 4 ). We noted seasonal patterns of travel-related infections, which differed between the international travellers (infection peak in November and December) and those who travelled from Hong Kong, Macau, or Taiwan (respiratory infections peak in February and June, mucocutaneous infection peak in May and July; appendix p 8).
Discussion
To our knowledge, ours is the first multicentre study of travel-related infections among travellers arriving in mainland China. We characterised the range of travel-related infections, and showed how they varied by traveller type, exposure country or region, and province of arrival to mainland China. Our findings, which are based on surveillance data for 45 infections among 22 797 travellers who arrived at the 272 entry-exit ports to the mainland, are helpful for increasing public health awareness about the potential risk of imported infections. Most previous studies about this topic in mainland China explored the epidemiological features of imported malaria, or febrile illnesses or HIV infection at a single entry-exit port. 8, 9, [19] [20] [21] [22] By comparison with GeoSentinel, a clinician-based global surveillance system that tracks infectious diseases and other adverse health outcomes related to travel, 23 we actively surveyed infections among travellers upon arrival in mainland China. This method enabled us not only to profile imported infections, identify risk groups, and formulate optimum advice for travellers (as done previously on the basis of data from GeoSentinel or its linked European surveillance network, EuroTravNet), [24] [25] [26] but also to estimate the incidence of each infection by using the total number of arrivals as denominator. Additionally, active surveillance of arriving travellers enables timely identification of imported infections, allowing for alerting of public health authorities of threats before autochthonous transmission.
Both case numbers and incidence of infection have increased over time among travellers arriving in mainland China (table) . This increase probably reflects the worldwide epidemic trend of infectious diseases. 27 Improvements in diagnostic procedures and rapid tests might have also contributed to the increase. Case numbers and incidence varied greatly between the 31 provinces, autonomous regions, and municipalities (figure 1), which implies that each province should optimise a unique strategy for surveillance of, and response to, specific infections.
The diagnostics used in our study were based on the surveillance technical scheme developed by AQSIQ, 16 whereby diagnosis was based on recommended specific laboratory tests. Accordingly, we classified diagnosis according to the main transmission route of each infection: respiratory, gastrointestinal, vector-borne, blood-trans mitted and sex-transmitted, and mucocutaneous. Over four-fifths of respiratory infections and about two-thirds of vector-borne and mucocutaneous infections were detected by fever screening (table), suggesting that fever screening is essential to identification of febrile patients. Our findings also suggest that medical inspection should be sustained to identify people with mucocutaneous infections other than hand, foot, and mouth disease or blood-transmitted and sex-transmitted infections, which are often associated with obvious clinical manifestations such as rashes, vomiting, and jaundice (appendix pp 9-10). Additionally, on-board staff should be encouraged to report patients they suspect of being infected for timely identification.
Chinese labourers (ie, Chinese people who work overseas, mostly in the manufacturing, construction, forestry, fishing, transportation, and catering industries, although some are highly skilled workers) abroad seemed prone to tuberculosis, hepatitis A virus infection, vectorborne infections, and blood-transmitted and sextransmitted infections ( figure 2C ). Pre-travel advice to labourers should focus on such public health threats. Additionally, we suggest that on-site health education and primary health care should be provided to Chinese labourers in the countries where they work. Rubella, acute conjunctivitis, and herpes zoster virus infections were frequently detected in sailors ( figure 2C ), suggesting that close contact and working in humid environments are risk factors for transmission of these infections.
Although the infection profiles of international travellers and travellers from Hong Kong, Macau, and Taiwan differed substantially, influenza was the most common infection in both groups (figure 3). Our findings show the epidemic pattern of influenza in different global regions, 28 and imply that vaccination should be considered if travelling to a region where influenza transmission is ongoing. 29 People with blood-transmitted and sextransmitted diseases were mostly male labourers and sailors (table). Although the reasons for high risk in these populations were unclear, our study shows the sociodemographic characteristics of people with these diseases arriving in mainland China, which were significantly associated with travel-associated sexually transmitted infections in data gathered by GeoSentinel travel medicine clinics worldwide. 30 Further research is required to investigate effective intervention measures.
Dengue and malaria were frequent among international travellers arriving from Africa (appendix p 7). Imported dengue has caused autochthonic transmission in new areas of China, Europe, and the USA. [31] [32] [33] [34] In our study, we also noted the arrival of patients with Zika virus, yellow fever virus, and Rift Valley fever to mainland China since February, 2016. [12] [13] [14] [15] Governments and the public health community should be aware of these new threats to prevent possible local epidemics.
In travellers from Hong Kong, Macau, and Taiwan, the incidence of hand, foot, and mouth disease was high (figure 3). We could not establish where these travellers were infected, because they usually travel frequently to and from mainland China. Detailed data about itineraries should be collected to help to clarify the infection exposure site. The warm and humid climate in Hong Kong, Macau, Taiwan, and southern China could favour transmission of hand, foot, and mouth disease. Fortunately, a vaccine against the EV71, the most prevalent virus strain, is commercially available and has a good protective effect. 35 We mapped travel-related infections globally to show differences in terms of exposure country and region ( figure 4) . Health-care professionals should be aware of the specific risks to travellers, and should provide targeted pre-travel consultations. Accordingly, countryspecific or region-specific vaccination and prophylaxis are strongly recommended to reduce the burden of travel-related infections.
Our study had several limitations. Because our findings were based on surveillance of travellers when entering mainland China, most cases had clinical manifestations of disease upon arrival (appendix pp 9-10). Patients who were infected but did not develop symptoms until after arrival were not included in our study. Thus, the frequency of travel-related infections are underestimated. By contrast, for infections such as tuberculosis, hepatitis B and C virus infections, HIV, and syphilis, which have long latent or incubation periods, the location of acquisition is difficult to establish. For example, Chinese citizens who travelled overseas and were diagnosed upon arrival back to mainland China could have acquired the infection before travelling. Thus, the frequency of such infection in arriving travellers could have been overestimated. Although we estimated the overall incidence of each infection, would could not calculate the numerical risk for travellers coming from a particular country or region because of the lack of denominator data. Furthermore, we could not compare the demographic characteristics of the 22 797 people with an infection to those without an infection, because demographic data were not collected for all arriving travellers.
In conclusion, our findings suggest that health-care providers should provide evidence-based health recommendations to travellers before travel and should do destination-specific medical assessments of arriving travellers who are ill. Active surveillance at entry-exit ports can help with timely identification of people with emerging or re-emerging infections to prevent or at least postpone local transmission. 36, 37 In addition to entry surveillance, follow-up surveillance-especially contact tracing of highly communicable infections-will be necessary to understand the entire profile of travel-related infections.
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